TCM
LLY icon

Traynor Capital Management’s Eli Lilly LLY Stock Holding History

Traynor Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7M Buy
54,814
+220
+0.4% +$225K 3.02% 8
2026
Q1 		$48.4M Sell
54,594
-49
-0.1% -$49.7K 2.84% 8
2025
Q4 		$58.7M Sell
54,643
-72
-0.1% -$68.8K 3.14% 7
2025
Q3 		$41.7M Sell
54,715
-879
-2% -$654K 2.38% 8
2025
Q2 		$43.1M Buy
55,594
+656
+1% +$510K 3.06% 6
2025
Q1 		$45.4M Buy
54,938
+3,907
+8% +$3.25M 3.82% 6
2024
Q4 		$39.4M Buy
51,031
+2,999
+6% +$2.48M 2.63% 8
2024
Q3 		$42.6M Buy
48,032
+5,375
+13% +$4.83M 2.55% 9
2024
Q2 		$38.6M Buy
42,657
+11,824
+38% +$9.46M 2.89% 8
2024
Q1 		$24M Buy
30,833
+8,563
+38% +$6.09M 2.08% 10
2023
Q4 		$13M Buy
22,270
+5,212
+31% +$3.04M 1.33% 14
2023
Q3 		$9.16M Buy
17,058
+5,398
+46% +$2.78M 1.15% 18
2023
Q2 		$5.47M Buy
11,660
+752
+7% +$315K 0.67% 34
2023
Q1 		$3.75M Buy
10,908
+2,725
+33% +$919K 0.54% 39
2022
Q4 		$2.99M Buy
8,183
+6,004
+276% +$2.13M 0.42% 43
2022
Q3 		$704K Buy
2,179
+793
+57% +$251K 0.13% 81
2022
Q2 		$449K Sell
1,386
-25
-2% -$7.5K 0.08% 99
2022
Q1 		$404K Buy
1,411
+161
+13% +$41.4K 0.05% 122
2021
Q4 		$345K Buy
1,250
+50
+4% +$12.7K 0.04% 144
2021
Q3 		$277K Buy
+1,200
New +$296K 0.04% 144
2015
Q2 		– Sell
-8,331
Closed -$605K – 146
2015
Q1 		$605K Buy
8,331
+2
+0% +$142 0.58% 35
2014
Q4 		$574K Buy
+8,329
New +$562K 0.67% 31

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Traynor Capital Management's LLY Position: Q2 2026 in Review

Traynor Capital Management increased its Eli Lilly (LLY) stake by 0.4% in Q2 2026, buying an estimated $225K and bringing the position to 54,814 shares worth $65.7M. The position accounts for 3.02% of the portfolio, ranked #8.

Traynor Capital Management first reported a position in LLY in Q4 2014 and has held it in 22 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Traynor Capital Management held 54,814 shares of Eli Lilly worth $65.7M as of Q2 2026.
  • Traynor Capital Management bought 220 Eli Lilly shares in Q2 2026, an estimated $225K.
  • Eli Lilly made up 3.02% of Traynor Capital Management's portfolio in Q2 2026, its #8 holding.
  • Traynor Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 22 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.